5-HT2 antagonist and 5-HT7 inverse agonist

brain penetrant, oral efficacy in rodent models

backup candidate to JNJ-18038683

Bioorg. Med. Chem. Lett., Nov. 7, 2020

Janssen, San Diego, CA

“compound 4j” (Janssen (JNJ) brain-penetrant in vivo 5-HT2 antagonist and 5-HT7 inverse agonist, backup candidate)


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks